Measuring antianginal drug efficacy using exercise testing for chronic angina: Improved exercise peformance with ranolazine, a pFOX inhibitor-Reference-Cited by-同舟云学术

Measuring antianginal drug efficacy using exercise testing for chronic angina: Improved exercise peformance with ranolazine, a pFOX inhibitor

Published:2002-12 Issue:12 Volume:27 Page:527-555
ISSN:0146-2806
Container-title:Current Problems in Cardiology
language:en
Short-container-title:Current Problems in Cardiology

Author:

Chaitman Bernard R.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference122 articles.

1. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina);Gibbons;Circulation,1999

2. Health status predicts long-term outcome in outpatients with coronary disease;Spertus;Circulation,2002

3. Angina severity and its importance in risk stratification and treatment decisions: the Canadian Cardiovascular Society Classification 25 years on;Boston;Circulation,2001

4. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomized trial;Dargie;Lancet,2002

5. Beta blockade during and after myocardial infarction: An overview of the randomized trials;Yusuf;Prog Cardiovasc Dis,1985

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of ranolazine in heart failure: From cellular to clinic perspective;European Journal of Pharmacology;2022-03

2. Angina pectoris: current therapy and future treatment options;Expert Review of Cardiovascular Therapy;2014-01-13

3. Ranolazine recruits muscle microvasculature and enhances insulin action in rats;The Journal of Physiology;2013-07-19

4. Effect of ranolazine on rat intrarenal arteries in vitro;European Journal of Pharmacology;2012-05

5. Effects of Ranolazine on Cloned Cardiac Kv4.3 Potassium Channels;Journal of Pharmacology and Experimental Therapeutics;2011-09-22